Bruce C. Cozadd, Chairman & CEO at Jazz Pharmaceuticals plc (JAZZ), sold 1,000 shares at $155.79 ($156K) on 2023-02-01, disclosed to the SEC on 2023-02-03.
Seasonal sale ($156k) by Chairman & CEO — this insider has traded JAZZ in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| JAZZ | SELL | 2026-07-06 | $1.4M | — | Filing → |
| JAZZ | SELL | 2026-06-03 | $1.4M | — | Filing → |
| JAZZ | SELL | 2026-05-05 | $1.2M | — | Filing → |